Clinical Trial

A Randomized, Comparative Study to Evaluate the Effect of RL3014A-DP0421 Mouthwash on the Oral Microbial Composition

Completed
View on ClinicalTrials.gov →
Summary
The Laboratoires Pierre Fabre has on the market a product range of daily use mouthwash, all containing 0.05% of O-Cymen -5-ol, a broad-spectrum bactericide. From other mouth rinses (reference mouthwash) it is known that they have a clear effect on the microbial composition of the tongue and saliva samples. RL3014A - DP0421, is the product of the range with the most representative formula. The aim of the study is to evaluate if the product RL3014A - DP0421 respects the buccal flora and does not show an undesired effect on the microbial equilibrium of the mouth.
Trial Details
NCT Number NCT07685782
Lead Sponsor Pierre Fabre Dermo Cosmetique
Conditions Healthy
Enrollment 109 participants
Start Date 2024-02-29
Primary Completion 2024-08-28 (estimated)
Study Completion 2024-08-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-06